When you start a weight loss program using medications like semaglutide or tirzepatide, you might assume the scale will only reflect fat leaving your body. Unfortunately, that's not quite how the human body works. Whether you lose weight through diet alone, surgery, or medication-assisted programs, your body typically breaks down a mix of fat tissue and lean muscle mass to fuel the deficit. This isn't unique to GLP-1 medications. It's a fundamental physiological response that has been documented across numerous weight loss studies for decades.
Clinical trials for medications like semaglutide have shown that a portion of total weight lost does come from lean body mass rather than adipose tissue alone. When caloric intake drops sharply, the body may shift into a catabolic state that pulls energy from multiple sources, including skeletal muscle. Understanding this baseline reality isn't meant to discourage anyone from pursuing treatment. Instead, it helps explain why adding protective strategies matters for anyone committed to long-term weight loss and health improvement.